BBAM closes third aviation fund above $1.7bn

About BBAM

  • Founded: 1993

  • Headquarters: Stamford, Connecticut, United States

  • AUM: $12bn+ (as of 2024)

  • Strategy: Aviation asset leasing and financing, aircraft sale-leaseback and portfolio acquisitions

  • Track record: Incline II raised $1.3bn in 2020; firm has deployed more than $30bn across commercial aircraft acquisitions since inception

  • Leadership: Steve Zissis, CEO and Co-Founder; Eddie Healy, Co-Founder

BBAM closed its third Incline fund above $1.7bn, having already committed more than $625m — approximately 37% of total capital — before final close. The fund focuses on commercial aircraft leasing and structured aviation finance. The raise represents a 31% increase over the $1.3bn predecessor fund closed four years earlier, tracking with the steady post-pandemic recovery in narrowbody demand and lease-rate stabilization.

Closing a fund with more than a third deployed signals either rapid deployment discipline or, more likely, a prolonged fundraise during which the GP kept investing at pace. For an asset class as capital-intensive as aircraft, early deployment can sharpen returns if the acquisitions hit a favorable market window — but it also constrains flexibility if the fundraising cycle stretches or market conditions shift mid-raise. BBAM's ability to place $625m while still marketing suggests strong conviction in near-term aircraft valuations, particularly for narrowbody platforms where lease rates firmed through 2023 as supply-chain delays kept delivery backlogs elevated.

The cleaner question is what the 37% figure tells us about portfolio construction risk. Aviation funds typically hold 20–40 aircraft at scale; $625m deployed likely translates to 8–12 aircraft if weighted toward younger narrowbodies. That's enough to establish sector exposure but not enough to lock in the fund's return profile — the remaining $1.1bn will determine whether BBAM caught the cycle correctly or whether lease-rate compression from OEM delivery acceleration over the next 18 months erodes margins on later purchases. For LPs, the litmus test is whether the deployed cohort outperforms the as-yet-uncommitted capital by enough to justify the fundraising timeline.

Source: AltAssets